Search Results - "Simargi, Shirleen"

Hyaluronic acid conjugated nanoparticle delivery of siRNA against TWIST reduces tumor burden and enhances sensitivity to cisplatin in ovarian cancer by Shahin, Sophia A., Wang, Ruining, Simargi, Shirleen I., Contreras, Altagracia, Parra Echavarria, Liliana, Qu, Louise, Wen, Wei, Dellinger, Thanh, Unternaehrer, Juli, Tamanoi, Fuyuhiko, Zink, Jeffrey I., Glackin, Carlotta A.

“…TWIST protein is critical to development and is activated in many cancers. TWIST regulates epithelial-mesenchymal transition, and is linked to angiogenesis,…”
Get full text

Chick chorioallantoic membrane assay as an in vivo model to study the effect of nanoparticle-based anticancer drugs in ovarian cancer by Vu, Binh Thanh, Shahin, Sophia Allaf, Croissant, Jonas, Fatieiev, Yevhen, Matsumoto, Kotaro, Le-Hoang Doan, Tan, Yik, Tammy, Simargi, Shirleen, Conteras, Altagracia, Ratliff, Laura, Jimenez, Chiara Mauriello, Raehm, Laurence, Khashab, Niveen, Durand, Jean-Olivier, Glackin, Carlotta, Tamanoi, Fuyuhiko

“…New therapy development is critically needed for ovarian cancer. We used the chicken egg CAM assay to evaluate efficacy of anticancer drug delivery using…”
Get full text

Abstract 2024: Hyaluronic acid conjugated nanoparticle delivery of siTWIST reduces tumor burden and enhances chemosensitivity in ovarian cancer by Glackin, Carlotta A., Shahin, Sophia A., Simargi, Shirleen, Wang, Ruining, Contreras, Altagracia, Parra, Liliana, Qu, Loiuse, Wen, Wei, Dellinger, Thanh, Unternaehrer, Julia, Tamanoi, Fuyujiko, Zink, Jeffrey

“…Abstract Purpose: TWIST is a transcription factor critical to embryonic development, and aberrantly activated in many cancers. It regulates…”
Get full text

Abstract 2152: Optimizing therapies for drug-resistant ovarian cancer stem cells using aCAM-PDX model by Contreras, Altagracia, Shahin, Sophia Allaf, Ratliff, Laura E., Simargi, Shirleen I., Wang, Ruining, Vu, Binh, Dellinger, Thanh H., Zink, Jeffrey I., Tamanoi, Fuyuhiko, Unternaehrer-Hamm, Julia, Glackin, Carlotta A.

“…Abstract Purpose: To develop rapidly operational CAM-PDX (chorioallantoic membrane-patient derived xenograft) tumor models that morphologically resemble human…”
Get full text